You are here

Prescription: Washington

Off-Label Drug Promotion Now on the Table

Stephen Barlas
PDF version: 
Stephen Barlas details the problems that might arise if drug manufacturers are permitted to market drugs for off-label purposes, especially antipsychotic agents, and the concerns of Congress that clinical trials will be lacking to support the new indications.